Begin main content

Reports

We found 6668 result(s)

2020 CADTH Symposium

Event Date: April 19, 2020 - April 21, 2020
Result type: Events

Join us in Toronto for the 2020 CADTH Symposium. Connect with Canadian and international experts in the objective assessment and evaluation of health technologies for three days of education, information sharing, and networking. Mark your calendar: 2020 CADTH Symposium
April 19 to 21, 2020
Sheraton Centre Toronto
Toronto, On...

Non-Pharmacological Interventions for Chronic Non-Cancer Pain: Acupuncture

Event Date: March 16, 2020
Result type: Events

Because of the prevalence and burden of chronic pain, and the associated opioid crisis in our country, health professionals are looking for non-pharmacological treatment options to recommend to their patients. Join CADTH for a webinar on the current evidence on acupuncture for chronic non-cancer pain. The target audience for this presentation i...

eculizumab (Soliris)

Last Updated: January 24, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: eculizumab
Indications: Neuromyelitis optica spectrum disorder

  • Brand Name: Soliris
  • Manufacturer: Alexion Pharma Canada Corp.
  • Project Number: SR0640-000
  • Project Status: Pending
  • Submission Type: New Indication

teduglutide (Revestive)

Last Updated: January 23, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: teduglutide
Indications: Short Bowel Syndrome (SBS), pediatrics

  • Brand Name: Revestive
  • Manufacturer: Shire Pharmaceuticals Ireland Limited
  • Project Number: SR0606-000
  • Project Status: Complete
  • Submission Type: New Indication

glucagon (Baqsimi)

Last Updated: January 24, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: glucagon
Indications: Severe hypoglycemic reactions

  • Brand Name: Baqsimi
  • Manufacturer: Eli Lilly Canada Inc.
  • Project Number: SR0626-000
  • Project Status: Active
  • Submission Type: New

caplacizumab (Cablivi)

Last Updated: January 24, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: caplacizumab
Indications: Acquired thrombotic thrombocytopenic purpura (aTTP)

  • Brand Name: Cablivi
  • Manufacturer: Sanofi-Genzyme, a division of sanofi-aventis Canada Inc.
  • Project Number: SR0633-000
  • Project Status: Active
  • Submission Type: New

budesonide (Jorveza)

Last Updated: January 24, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: budesonide
Indications: Eosinophilic esophagitis, adults

  • Brand Name: Jorveza
  • Manufacturer: AVIR Pharma Inc.
  • Project Number: SR0634-000
  • Project Status: Active
  • Submission Type: New

apomorphine hydrochloride (Kynmobi)

Last Updated: January 23, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: apomorphine hydrochloride
Indications: Parkinson’s Disease

  • Brand Name: Kynmobi
  • Manufacturer: Sunovion Pharmaceuticals Canada Inc.
  • Project Number: SR0604-000
  • Project Status: Withdrawn
  • Submission Type: New